Article Information
History
- November 21, 2021.
Article Versions
- You are currently viewing Version 1 of this article (November 21, 2021 - 08:55).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Penda Johm1,
- Oluwatosin Nkereuwem1,
- Aji-Matty Manjang1,
- Omar Ceesay1,
- Lamin Leigh1,
- Amie Ceesay1,
- Mustapha Bittaye2,
- Adeyemi Roberts2,
- Buba Manjang2,
- Sana Sambou2,
- Sainey Sanneh2,
- Lamin Saidy1,
- Binta Saidy1 and
- Beate Kampmann1,3,*
- 1Vaccines and Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia
- 2Ministry of Health, Quadrangle, Banjul, The Gambia
- 3The Vaccine Centre, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
- ↵*Corresponding author: Professor Beate Kampmann; bkampmann{at}mrc.gm, Vaccines and Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia